Lunch Symposium at the EACTS 2022
October 7th 2022

Hemoadsorption with CytoSorb in high-risk cardiac surgery indications – new data

00:00 - 0:01:02 Introduction and moderation
Piotr Suwalski, Warsaw/Poland and Christophe Baufreton, Angers/France

0:01:03 - 0:20:03 Removal of antithrombotic drugs to reduce bleeding complications and costs in high-urgency operations
Michael Schmoeckel, Hamburg/Germany

0:20:04 - 0:45:38 Clinical benefits in patients undergoing heart transplantation – results of a single center RCT
Endre Németh, Budapest/Hungary

0:45:39 - 1:14:26 CytoSorb in infective endocarditis patients – what can we learn from recent data?
Matthias Thielmann, Essen/Germany